necrot
enterocol
nec
common
seriou
acquir
gastrointestin
disord
newborn
infant
although
mani
variabl
associ
develop
nec
prematur
consist
identifi
casecontrol
studi
tradit
dive
seal
reflex
invok
mechan
respons
ischaem
injuri
necrosi
intestin
ischaemia
like
final
common
pathway
nec
howev
due
releas
vasoconstrict
substanc
platelet
activ
factor
rather
perinat
asphyxia
bacteria
andor
bacteri
toxin
like
key
role
pathogenesi
nec
foster
product
inflammatori
mediat
role
feed
practic
pathogenesi
nec
remain
controversi
treatment
infant
nec
gener
includ
regimen
bowel
rest
gastric
decompress
system
antibiot
parenter
nutrit
infant
perfor
gener
oper
upon
howev
recent
interest
primari
periton
drainag
altern
prevent
nec
still
remain
elus
avoid
preterm
birth
use
antenat
steroid
breastmilk
feed
practic
offer
greatest
potenti
benefit
use
strategi
await
trial
necrot
enterocol
nec
common
seriou
acquir
gastrointestin
diseas
newborn
infant
affect
neonat
intens
care
unit
nicu
admiss
nation
center
health
statist
multicentr
trial
estim
case
per
year
usa
result
death
term
necrot
enterocol
first
appear
european
literatur
earli
articl
schmid
quaiser
describ
infant
die
necrot
lesion
gastrointestin
tract
howev
santulli
et
al
report
seri
preterm
infant
nec
babi
hospit
becam
recogn
distinct
clinic
entiti
infant
nec
repres
sickest
infant
nicu
exhibit
mortal
rate
rang
furthermor
infant
definit
diagnos
nec
except
support
care
littl
one
alter
cours
diseas
incid
nec
may
increas
infant
weigh
less
g
surviv
popul
infant
suscept
nec
like
requir
surgeri
greater
probabl
die
diseas
origin
report
santulli
et
al
describ
preterm
infant
critic
ill
often
low
apgar
score
commonli
requir
placement
umbil
arteri
cathet
manag
respiratori
distress
syndrom
rd
follow
institut
formula
feed
affect
infant
develop
abdomin
distent
bloodi
stool
abdomin
radiograph
demonstr
cardin
sign
nec
pneumatosi
intestinali
case
rapid
progress
perfor
base
clinic
observ
infant
studi
experiment
anim
three
factor
felt
necessari
nec
occur
mucos
injuri
asphyxia
cathet
formula
feed
provid
substrat
bacteri
ferment
presenc
bacteria
lack
improv
mortal
rate
nec
past
year
prompt
investig
reexamin
epidemiolog
factor
search
strategi
prevent
diseas
articl
review
controversi
concept
epidemiolog
pathogenesi
nec
recent
clinic
trial
design
prevent
nec
result
mani
advanc
neonat
intens
care
nec
emerg
diseas
nicu
survivor
overal
incid
case
per
live
birth
consider
variat
observ
among
institut
even
within
institut
although
case
report
fullterm
infant
diseas
predominantli
affect
prematur
infant
incid
vari
invers
birthweight
gestat
age
suscept
appear
infant
weigh
less
g
birth
week
gestat
data
nation
institut
child
health
human
develop
neonat
network
nichd
neonat
network
vermontoxford
trial
network
confirm
increas
incid
among
verylowbirthweight
vlbw
infant
risk
nec
persist
postconceptu
age
least
week
reach
major
nec
case
endem
howev
epidem
may
also
occur
season
pattern
report
studi
male
femal
infant
equal
affect
age
onset
also
invers
relat
gestat
age
fullterm
infant
nec
appear
occur
median
age
two
day
greater
present
first
day
life
immatur
infant
continu
prolong
risk
nec
born
week
gestat
younger
may
symptomat
sever
week
nec
diagnos
clinic
present
appear
rel
similar
among
affect
infant
modifi
bell
stage
system
nec
shown
tabl
although
common
present
abdomin
distent
report
sign
includ
feed
intoler
haematochezia
lethargi
apnoea
respiratori
failur
circulatori
instabl
affect
infant
also
exhibit
vari
degre
laboratori
abnorm
leukopenia
leukocytosi
anaemia
thrombocytopenia
hypoor
hyperglycaemia
electrolyt
abnorm
metabol
acidosi
bacteraemia
document
case
although
singl
pathogen
consist
identifi
escherichia
coli
klebsiella
enterobact
pseudomona
salmonella
clostridium
perfring
c
difficil
c
butyricum
coagulaseneg
staphylococci
enterococcu
coronaviru
rotaviru
enteroviru
associ
nec
type
organ
recov
vari
diseas
sever
modifi
bell
stage
ii
nec
gramposit
organ
appear
predomin
pathogen
recov
nec
worsen
enter
organ
commonli
isol
radiograph
affect
infant
display
sign
pneumatosi
intestinali
accumul
ga
produc
gasform
bacteria
submucosa
subserosa
sign
intestin
gangren
impend
perfor
portal
venou
ga
pvg
fix
distend
bowel
loop
free
intraperiton
fluid
pneumoperitoneum
pvg
believ
repres
either
dissect
ga
bowel
portal
vein
transfer
portal
system
via
mesenter
vein
prognost
import
controversi
ultrasonographi
propos
use
adjunct
identif
pneumatosi
intestinali
free
intraperiton
fluid
pvg
approxim
affect
infant
requir
surgic
intervent
major
postop
complic
relat
stoma
wound
strictur
found
primarili
colon
may
occur
infect
infant
nec
report
recur
infant
howev
consist
associ
shown
recurr
feed
regimen
anatom
site
injuri
manag
initi
diseas
total
parenter
nutrit
tpn
relat
complic
may
also
occur
infant
nec
also
extend
hospit
day
medic
nec
day
surgic
nec
beyond
healthi
match
control
although
vlbw
infant
sever
diseas
may
higher
risk
advers
outcom
neurodevelopment
outcom
measur
school
age
appear
favour
infant
although
nec
import
caus
neonat
morbid
mortal
pathogenesi
remain
incomplet
understood
avail
theori
explain
spectrum
observ
manifest
diseas
satisfactorili
nec
like
repres
complex
interact
factor
predispos
mucos
injuri
infant
subsequ
respons
intestin
ischaemia
clearli
occur
nec
evidenc
histopatholog
presenc
inflammatori
cell
infiltr
mucos
oedema
ulcer
coagul
necrosi
howev
unclear
whether
ischaemia
primari
initi
end
result
intestin
injuri
earli
observ
studi
report
signific
associ
numer
ischaem
event
develop
nec
factor
often
cite
possibl
risk
factor
perinat
asphyxia
umbil
arteri
catheter
polycythaemia
exchang
transfus
rd
cyanot
congenit
heart
diseas
medic
indomethacin
methylxanthin
shown
decreas
superior
mesenter
blood
flow
also
implic
mani
perinat
insult
believ
induc
dive
seal
reflex
blood
flow
select
shunt
away
nonvit
organ
intestin
howev
physiolog
mechan
fulli
explain
seen
clinic
mani
infant
nec
histori
perinat
depress
birth
present
sign
nec
sever
week
life
recent
epidemiolog
studi
also
fail
confirm
associ
hypox
factor
develop
nec
conflict
data
suggest
ischaemia
may
secondari
event
reflect
culmin
variou
factor
describ
prematur
factor
consist
found
epidemiolog
studi
independ
determin
nec
increas
suscept
attribut
immatur
mucos
barrier
barrier
respons
presenc
low
intralumin
gastric
acid
proteolyt
activ
incomplet
innerv
poorli
organ
rel
permeabl
epitheli
barrier
vulner
bacteri
colon
pathogen
overgrowth
prematur
infant
humor
cellular
respons
overgrowth
impair
specif
secretori
iga
defici
lymphfolliclerich
termin
ileum
colon
facilit
bacteri
transloc
inadequ
tlymphocyt
activ
compromis
recognit
ensu
membran
alter
enter
feed
implic
signific
contributor
develop
nec
although
nec
occur
infant
never
fed
case
occur
infant
histori
recent
volum
advanc
reiniti
enter
feed
introduct
feed
intestin
lumen
presum
caus
disrupt
mucos
integr
blood
flow
motil
substanti
higher
incid
nec
report
formulaf
infant
compar
exclus
breastf
infant
attribut
lack
immunoprotect
factor
time
initi
volum
advanc
feed
import
factor
determin
degre
mucos
insult
occur
sinc
much
research
perform
area
conflict
consensu
reach
regard
effect
feed
regimen
welldocu
epidem
nec
improv
attack
rate
follow
implement
strict
infect
control
measur
valid
role
infect
pathogenesi
nec
role
bacteria
twofold
ferment
carbohydr
substrat
bacteria
lead
format
hydrogen
ga
ga
found
pneumatosi
intestinali
furthermor
mucos
integr
compromis
bacteria
transloc
region
lymph
node
activ
resid
macrophag
colon
intestin
bacteri
speci
must
preced
bacteri
transloc
physiolog
growth
intestin
microflora
patholog
modif
microflora
assess
fecal
bacteri
measur
organ
introduc
steril
fetal
intestin
contact
matern
vagin
flora
speci
e
coli
streptococci
bacteroid
commonli
isol
immedi
neonat
period
colon
aerob
anaerob
flora
normal
occur
day
age
first
week
month
rel
concentr
e
coli
streptococci
declin
concentr
lactobacilli
bacteroid
rise
introduct
enter
feed
alter
pattern
intestin
colon
formula
associ
earli
appear
enterobacteriacea
e
coli
klebsiella
wherea
breast
feed
induc
earli
appear
enterobacteriacea
bifidobacterium
regardless
choic
feed
bifidobacteria
gradual
becom
domin
bacteria
infant
requir
neonat
intens
care
colon
occur
slowli
follow
initi
feed
infant
speci
present
hospit
remain
uncompl
enter
colon
continu
diversifi
howev
colon
often
delay
revers
interrupt
feed
regimen
administr
broadspectrum
antibiot
clinic
delay
colon
appear
roughli
correspond
delay
diseas
present
substanti
alter
intestin
flora
enabl
bacteri
overgrowth
organ
result
lack
competit
role
bacteri
toxin
less
clear
lawrenc
et
al
hypothes
bacteri
toxin
absorpt
period
bacteri
overgrowth
primari
mechan
intestin
damag
howev
isol
potent
toxin
clostridium
toxin
asymptomat
infant
rais
question
import
toxinmedi
injuri
evolut
nec
bacteri
transloc
toxin
absorpt
occur
endogen
product
inflammatori
mediat
like
key
step
pathogenesi
nec
anim
studi
demonstr
increas
tumour
necrosi
factor
tnf
platelet
activ
factor
paf
propag
ongo
injuri
intestin
mucosa
trigger
cascad
inflammatori
event
inflammatori
respons
consist
leukocyt
adhes
activ
complement
activ
releas
cytokin
reactiv
oxygen
speci
nitric
oxid
result
area
focal
necrosi
clinic
elev
paf
tnf
level
reduc
level
paf
acetylhydrolas
enzym
degrad
paf
observ
infant
nec
imbal
proand
counterinflammatori
cytokin
may
partial
explain
vari
sever
diseas
immatur
enterocyt
injuri
may
stimul
excess
proinflammatori
cytokin
product
howev
attempt
correl
cytokin
level
develop
progress
nec
gener
unsuccess
follow
clinic
diagnosi
nec
mainstay
treatment
remain
medic
stabil
regimen
consist
bowel
rest
gastric
decompress
system
antibiot
parenter
nutrit
typic
implement
initi
broadspectrum
antibiot
coverag
institut
consist
ampicillin
gentamicin
clindamycin
increas
preval
infect
coagulaseneg
staphylococcu
vancomycin
may
use
instead
ampicillin
amikacin
metronidazol
substitut
gentamicin
clindamycin
other
howev
antimicrobi
choic
guid
local
resist
pattern
enter
antibiot
recommend
prompt
correct
electrolyt
abnorm
persist
metabol
acidosi
coagulopathi
also
recommend
case
persist
clinic
deterior
sign
impend
perfor
intestin
gangren
present
oper
intervent
may
consid
absenc
pneumoperitoneum
abdomin
paracentesi
may
help
confirm
presenc
intestin
gangren
use
conjunct
avail
data
current
intestin
perfor
remain
absolut
indic
laparotomi
cardin
principl
surgic
manag
excis
grossli
necrot
segment
exterior
viabl
end
allow
continu
bowel
decompress
recent
primari
periton
drainag
ppd
propos
altern
surgic
treatment
ein
et
al
first
describ
use
ppd
perfor
nec
vlbw
infant
howev
use
limit
unstabl
vlbw
infant
although
initi
implement
tempor
measur
multipl
publish
report
document
success
use
ppd
adjunct
therapi
prior
plan
laparotomi
lap
definit
therapi
particularli
extremelylowbirthweight
infant
less
g
metaanalysi
moss
et
al
also
demonstr
compar
combin
probabl
surviv
infant
perfor
nec
treat
either
procedur
lap
group
vs
ppd
group
even
presenc
signific
treatment
assign
bia
favour
lap
group
nec
step
prospect
multicentr
random
control
trial
current
way
examin
effect
ppd
vs
lap
primari
therapi
perfor
nec
vlbw
infant
stratifi
birthweight
g
potenti
extens
use
periton
drain
nec
moor
patch
drain
wait
laparotomi
approach
consist
limit
patch
major
perfor
gastrostomi
tube
drainag
bilater
periton
drain
longterm
parenter
nutrit
case
isol
multifoc
nec
investig
advoc
resect
primari
anastomosi
massiv
pneumatosi
intestinali
without
definit
intestin
gangren
present
proxim
divers
via
high
jejunostomi
recommend
minim
bacteri
prolifer
contrast
enema
typic
perform
prior
reiniti
feed
infant
perfor
nec
feed
intoler
develop
infant
medic
nec
approxim
onequart
affect
infant
may
develop
short
gut
syndrom
success
intestin
transplant
report
subset
although
experi
limit
overal
report
oneand
threeyear
surviv
rate
respect
strategi
prevent
nec
fall
two
major
categori
probabl
proven
efficaci
tabl
unproven
efficaci
base
upon
limit
data
tabl
interpret
studi
import
focu
overal
incid
nec
intervent
control
group
well
incid
stage
exampl
intervent
decreas
incid
stage
diseas
suspect
nec
relev
intervent
decreas
incid
stage
ii
iii
diseas
surprisingli
mani
suggest
intervent
direct
modifi
feed
practic
sinc
infant
nec
receiv
milk
feed
prior
onset
diseas
mani
year
breast
milk
advoc
way
prevent
nec
year
ago
barlow
et
al
demonstr
breast
milk
protect
rodent
model
nec
surprisingli
observ
engend
lot
enthusiasm
use
breast
milk
prevent
nec
unfortun
expect
breast
milk
would
protect
fulfil
nec
occur
infant
fed
exclus
human
milk
especi
milk
refriger
frozen
pasteur
investig
suggest
sever
nec
less
infant
fed
human
milk
recent
studi
dvorak
et
al
lend
support
observ
use
rat
model
nec
investig
demonstr
rat
breast
milk
reduc
incid
sever
nec
noteworthi
freez
thaw
elimin
protect
effect
matern
milk
studi
protect
effect
rat
breast
milk
associ
increas
product
antiinflammatori
cytokin
site
injuri
fresh
human
milk
howev
contain
numer
immunoprotect
substanc
immunoglobulin
lysozym
lactoferrin
macrophag
lymphocyt
neutrophil
bioactiv
factor
tabl
addit
human
milk
contain
paf
acetylhydrolas
enzym
destroy
paf
paf
one
mediat
thought
import
pathogenesi
nec
fresh
milk
also
promot
colon
lactobacillu
bifidu
may
also
offer
protect
see
mcguir
anthoni
recent
publish
systemat
review
studi
compar
donor
human
milk
formula
prevent
nec
preterm
infant
fig
eleven
trial
appear
relev
screen
four
fulfil
inclus
criteria
although
none
trial
show
statist
signific
reduct
incid
confirm
nec
metaanalysi
demonstr
borderlin
statist
signific
differ
rr
ci
import
note
studi
chosen
inclus
conduct
year
ago
may
repres
current
nicu
practic
popul
insuffici
data
show
use
preterm
human
milk
vs
preterm
formula
reduc
incid
nec
eibl
et
al
publish
result
random
clinic
trial
demonstr
reduct
incid
nec
preterm
infant
fed
oral
igaigg
prepar
report
follow
sever
studi
investig
whether
oral
immunoglobulin
prepar
result
reduct
incid
diseas
foster
cole
recent
publish
metaanalysi
studi
employ
strategi
five
studi
oral
immunoglobulin
prevent
nec
review
three
met
inclus
criteria
metaanalysi
review
conclud
evid
support
administr
oral
immunoglobulin
tabl
strategi
prevent
necrot
enterocol
probabl
proven
efficaci
breast
feed
antenat
steroid
fluid
restrict
enter
administr
antibiot
potenti
develop
resist
flora
tabl
strategi
prevent
necrot
enterocol
unproven
efficaci
limit
data
cautiou
advanc
feed
trophic
feed
enter
administr
immunoglobulin
b
supplement
larginin
c
supplement
feed
egg
phospholipid
c
acidif
milk
feed
c
administr
probiot
c
unproven
efficaci
b
efficaci
c
limit
data
prevent
nec
rr
definit
nec
ci
contrast
metaanalysi
studi
compar
restrict
vs
liber
water
intak
preterm
infant
fig
conclud
restrict
water
intak
without
allow
signific
dehydr
reduc
incid
nec
rr
ci
similarli
recent
metaanalysi
prophylact
enter
antibiot
prevent
nec
fig
demonstr
signific
reduct
incid
diseas
rr
ci
necrel
death
rr
ci
howev
potenti
risk
develop
resist
bacteria
strategi
adopt
larg
trial
investig
possibl
harm
effect
complet
recent
recommend
limit
increment
feed
volum
decreas
likelihood
develop
nec
recommend
base
retrospect
data
demonstr
relationship
rate
feed
advanc
increas
incid
nec
prospect
random
trial
reach
similar
conclus
berseth
et
al
compar
tradit
enter
feed
protocol
use
modest
feed
advanc
mlkg
day
minim
enter
feed
protocol
advanc
day
studi
termin
infant
random
significantli
higher
incid
nec
feed
advanc
group
feed
advanc
may
contribut
increas
incid
nec
also
possibl
minim
enter
feed
help
protect
nec
support
use
trophic
feed
critic
ill
preterm
infant
probiot
anaerob
bacteri
supplement
organ
bifidobacteria
lactobacilli
use
mani
year
treat
varieti
gastrointestin
diseas
bifidobacteria
common
organ
recov
gastrointestin
tract
breastf
infant
inhibit
colon
pathogen
organ
furthermor
bifidobacteria
fail
activ
key
mediat
inflammatori
cascad
enhanc
immun
function
periton
macrophag
degrad
intestin
mucou
glycoprotein
anim
model
nec
bifidobacteri
supplement
bifidobacterium
infanti
reduc
incid
nec
vs
e
colitr
anim
addit
bifidobacteria
reduc
plasma
concentr
endotoxin
intestin
gene
express
phospholipas
enzym
import
inflammatori
cascad
similar
protect
effect
bifidobacteria
demonstr
quail
model
nec
model
colon
bifidobacteria
infantislongum
decreas
colon
c
butyricum
reduc
product
butyr
acid
chemic
may
cytotox
intestin
epithelium
limit
data
human
newborn
infant
artifici
colon
bifidobacteria
random
clinic
trial
assess
potenti
toxic
kitajima
et
al
administ
bifidobacteria
breve
prematur
infant
advers
effect
attribut
bacteria
colon
infant
exhibit
better
weight
gain
toler
feed
recent
hoyo
colon
infant
lactobacillu
acidophilu
b
infanti
demonstr
decreas
incid
nec
necrel
mortal
vs
histor
control
safeti
probiot
supplement
determin
larg
prospect
trial
lactobacilli
bifidobacteria
capabl
caus
infect
human
especi
immunocompromis
host
therefor
strategi
use
studi
complet
number
retrospect
prospect
studi
examin
prevent
strategi
nec
part
secondari
analysi
random
trial
feed
preterm
infant
formula
supplement
supplement
egg
phospholipid
carlson
et
al
demonstr
significantli
lower
incid
stage
ii
iii
nec
phospholipid
contain
arachidon
acid
substrat
intestin
vasodilatori
cytoprotect
eicosanoid
furthermor
caplan
et
al
demonstr
supplement
formula
polyunsatur
fatti
acid
reduc
incid
death
nec
rat
pup
decreas
indic
inflamm
doubleblind
placebocontrol
trial
amin
et
al
investig
benefit
supplement
diet
preterm
infant
larginin
mmolkg
day
arginin
substrat
product
nitric
oxid
import
vasodil
antiinflammatori
mediat
infant
receiv
supplement
significantli
lower
incid
nec
compar
control
question
applic
studi
nicu
high
incid
nec
control
group
lastli
carrion
egan
prospect
doubleblind
studi
investig
whether
acidif
milk
ml
n
hclml
milk
decreas
incid
nec
infant
hcl
supplement
group
demonstr
lower
gastric
ph
reduc
incid
nec
includ
stage
nec
conclus
strategi
proven
efficaci
decreas
incid
nec
avoid
preterm
birth
use
antenat
steroid
preterm
deliveri
breastmilk
feed
use
trophic
feed
proven
benefit
seem
reason
use
prevent
strategi
await
result
trial
prematur
consist
determin
nec
incid
vari
invers
birthweight
gestat
age
time
present
also
vari
invers
gestat
age
intestin
ischaemia
appear
final
pathway
primari
initi
nec
nec
like
repres
elabor
interact
factor
predispos
mucos
injuri
includ
releas
vasoconstrict
substanc
inflammatori
mediat
regimen
consist
bowel
rest
gastric
compress
system
broadspectrum
antibiot
parenter
nutrit
mainstay
treatment
intestin
perfor
remain
absolut
indic
laparotomi
primari
periton
drainag
may
altern
laparotomi
case
perfor
nec
verylowbirthweight
infant
avoid
preterm
birth
judici
use
antenat
steroid
preterm
deliveri
breastmilk
feed
trophic
feed
may
reason
strategi
reduc
incid
nec
prevent
nec
still
remain
elus
better
understand
risk
factor
underli
pathway
lead
nec
determin
role
feed
practic
pathogenesi
nec
clarif
efficaci
safeti
probiot
supplement
develop
predict
model
risk
nec
